20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with transforming growth factor beta in 4 studies
| Studies (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Trials (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Recent Studies (post-2010) (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Studies (transforming growth factor beta) | Trials (transforming growth factor beta) | Recent Studies (post-2010) (transforming growth factor beta) |
|---|---|---|---|---|---|
| 640 | 13 | 233 | 49,119 | 560 | 17,610 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dahly-Vernon, AJ; Ledbetter, SR; McCarthy, ET; Roman, RJ; Savin, VJ; Sharma, M | 1 |
| Ives, HE; Liang, CJ; Ma, YH; Yang, CM | 1 |
| Chen, H; Chen, X; Duan, C; Li, Y; Liu, Y; Qin, T; Wang, C; Yang, J; Zhang, J; Zhou, X | 1 |
| Lai, G; Sun, R; Wu, J; Zhang, B; Zhao, Y | 1 |
4 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and transforming growth factor beta
| Article | Year |
|---|---|
Transforming growth factor-beta, 20-HETE interaction, and glomerular injury in Dahl salt-sensitive rats.
Topics: Animals; Hydroxyeicosatetraenoic Acids; Hypertension; In Vitro Techniques; Kidney; Kidney Glomerulus; Microscopy, Electron; Permeability; Rats; Rats, Inbred Dahl; Rats, Sprague-Dawley; Serum Albumin, Bovine; Sodium Chloride, Dietary; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2005 |
20-HETE inhibits the proliferation of vascular smooth muscle cells via transforming growth factor-beta.
Topics: Animals; Cell Proliferation; Cells, Cultured; Cyclin D1; DNA; Extracellular Signal-Regulated MAP Kinases; Humans; Hydroxyeicosatetraenoic Acids; Mitogen-Activated Protein Kinase Kinases; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Rats; Transforming Growth Factor beta | 2008 |
Inhibition of CYP4A by a novel flavonoid FLA-16 prolongs survival and normalizes tumor vasculature in glioma.
Topics: Angiogenesis Inhibitors; Animals; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chalcones; Culture Media, Conditioned; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Endothelial Progenitor Cells; Flavonoids; Glioma; Humans; Hydroxyeicosatetraenoic Acids; Macrophages; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Neovascularization, Pathologic; Paracrine Communication; Pericytes; Rats, Wistar; Time Factors; Transforming Growth Factor beta; Tumor Burden; Tumor Microenvironment; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2017 |
20-HETE regulated PSMB5 expression via TGF-β/Smad signaling pathway.
Topics: Animals; Gene Expression Regulation; Hydroxyeicosatetraenoic Acids; Kidney; Liver; Male; Mice; Proteasome Endopeptidase Complex; Signal Transduction; Smad Proteins; Transforming Growth Factor beta | 2018 |